✦ LIBER ✦

No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity

✍ Scribed by Hein J. Verberne; Kora de Bruin; Jan B. A. Habraken; G. Aernout Somsen; Jos L. H. Eersels; Frits Moet; Jan Booij; Berthe L. F. van Eck–Smit

Publisher: Springer
Year: 2006
Tongue: English
Weight: 203 KB
Volume: 33
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-005-0022-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical performance and radiation dosim

Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity

✍ Hein J. Verberne; Ellinor Busemann Sokole; Astrid F. van Moerkerken; Joop H. W. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 253 KB

Synthesis of three no-carrier-added O6-4

Synthesis of three no-carrier-added O6-4-[125I] iodobenzylguanosine derivatives, new reagents for the assay of O6-alkylguanine-DNA alkyltransferase activity

✍ Emmanuelle Mounetou; Catherine Cussac; Frédérique Mathieu; Jean-Claude Maurizis; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 461 KB

## Abstract O^6^‐alkylguanine‐DNA alkyltransferase (AGT) is mainly responsible for tumour resistances observed in chemotherapeutic treatments by chloroethylnitrosoureas (CENUs). Measurement of AGT activity is thereby essential to predict the response of the patients to therapy with CENUs. In order